6945-94-4Relevant articles and documents
Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity
Thabit, Mohamed G.,Mostafa, Amany S.,Selim, Khalid B.,Elsayed, Magda A.A.,Nasr, Magda N.A.
, (2020/08/07)
Three new series of phenyl dihydropyridazinone derivatives 4b–8i have been designed, synthesized and evaluated for their anticancer activity against different cancer cell lines. Nine compounds showed strong inhibitory activity, among which compound 8b exh
Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities
Amin, Enas Nashaat,Abdel-Alim, Abdel-Alim M.,Abdel-Moty, Samia G.,El-Shorbagi, Abdel-Naser A.,Abdel-Rahman, Mahran Sh.
scheme or table, p. 25 - 46 (2011/12/02)
4,5-dihydro-3(2H)pyridazinones such as CI-914, CI-930 and pimobendan along with tetrahydropyridopyridazine (endralazine) and perhydropyridazinodiazepine (cilazopril) have been used as potent positive inotropes, antihypertensives as well as platelet aggreg
N-(4-(PIPERAZIN-1-YL)-PHENYL-2-OXAZOLIDINONE-5-CARBOXAMIDE DERIVATES AND RELATED COMPOUNDS AS ANTIBACTERIAL AGENTS
-
Page/Page column 99, (2010/02/07)
The present invention provides antibacterial agents having the formula I described herein. or-pharmaceutically acceptable salts thereof wherein: A is a structure i, ii, iii, or iv,W is N(H)C(X)-R,. Het, or -Y HET, in which the Hot or Y HET is option